Does Eylea give a chance to improve if Avastin didn't help?

Avastin is a preparation with bevacizumab, and Eylea contains aflibercept. Aflibercept under the name Eylea is found as a therapeutic option in the B.70 drug program for patients with age-related exudative macular degeneration (AMD). To receive Eylea under the drug program, you must meet a total of specific eligibility criteria: 1) the presence of active (primary or secondary), classical, latent or mixed subretinal neovascularization (CNV) occupying more than 50% of the change in amd confirmed by OCT (optical coherent tomography) and fluorescein angiography or angio-OCT; 2) age over 45 years of age; 3) lesion size less than 12 DA (12 surfaces of the optic nerve disc); (4) the best corrected visual acuity (BCVA) in the treated eye 0,2-0,8 as determined by the Snellen table (or ETDRS equivalent, respectively); 5) the patient's consent to perform intravitreal injections; (6) the absence of predominant geographical disappearance; 7) the absence of a dominant hemorrhage; 8) before the start of treatment, there is no significant, permanent damage to the structure of the dimple (significant damage to the structure is defined as present fibrosis or atrophy in the dimple or significant chronic disc scar). If your doctor has not offered you to join the program, I suspect that you do not meet one or more of the above criteria. Disqualification from the program does not mean, however, that no further treatment makes sense. However, it is very difficult for me to assess whether the state of your health actually does not promise improvement after changing the therapy. Such an opinion can only be issued by an ophthalmologist familiar with all the details of your medical records. Unfortunately, medical opinions are not always unanimous. I enclose information that may be of interest to you: https://www.gdziepolek.pl/produkty/28887/eylea-iniekcja/apteki/w-warszawie https://www.gdziepolek.pl/kategorie/leczenie-zwyrodnienia-plamki-zwiazanego-z-wiekiem-amd https://www.gdziepolek.pl/kategorie/programy-lekowe-nowoczesne-terapie